Clinical Trials Logo

African Americans clinical trials

View clinical trials related to African Americans.

Filter by:
  • None
  • Page 1

NCT ID: NCT05473026 Completed - Exercise Clinical Trials

Grateful Strides Toward Physical Activity and Well-Being for Black Breast Cancer Survivors

Start date: November 8, 2022
Phase: N/A
Study type: Interventional

This pilot study will assess the feasibility of a gratitude intervention to promote physical activity, and well-being and positively impact biomarkers of health among older African American breast cancer survivors. The intervention will also include a goal-setting component to promote exercise readiness and examine the cultural phenomena of the Superwoman schema among Black women.

NCT ID: NCT05234125 Recruiting - Pregnancy Related Clinical Trials

Better Lifestyle Counseling for African American Women During Pregnancy

BETTER
Start date: August 16, 2022
Phase: N/A
Study type: Interventional

The purpose of this randomized controlled trial is to establish the effectiveness of a culturally targeted and individually tailored behavioral intervention to promote maternal glucose metabolism in African American women.

NCT ID: NCT04230928 Active, not recruiting - Hypertension Clinical Trials

Giving a Low Carbohydrate Diet to Overcome Hypertension

GLOH
Start date: March 5, 2020
Phase: N/A
Study type: Interventional

This study will test the preliminary efficacy of adding a very low carbohydrate dietary intervention to the evidence-based DPP-GLB on blood pressure reductions for lower-income AA men and women in a community-based clinic.

NCT ID: NCT03861832 Recruiting - Clinical trials for Substance Use Disorders

SMART Brain Health in African-Americans

SMART
Start date: June 16, 2018
Phase: N/A
Study type: Interventional

The investigators hypothesize that opioid use in African-Americans will be associated with hypodopaminergic alleles that alter the threshold for activating feelings of reward and pleasure within the dopaminergic system, and that these allelic frequencies will differ significantly from European Americans. Planned is a targeted system to study genetic risks for reward deficiency using risk gene panel to assign a genetic addiction risk score (GARS), comprehensive surveys to determine quality of life and exposure to stressors and trauma. This system will allow prediction of addiction and relapse potential and delivery of personalized treatment.